Atlas Trials

Evelo Biosciences, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Evelo Biosciences, Inc.

RecordFirmDate
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials (NCT05439941)Evelo Biosciences, Inc.2022-06-06
A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis (NCT05121480)Evelo Biosciences, Inc.2022-01-31
Scintigraphy Study to Evaluate the Gastrointestinal Behavior of EDP1815 Oral Dosage Forms (NCT05066373)Evelo Biosciences, Inc.2021-08-09
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma (NCT04927195)Evelo Biosciences, Inc.2021-02-23
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis (NCT04603027)Evelo Biosciences, Inc.2020-09-21
Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection (NCT04488575)Evelo Biosciences, Inc.2020-08-26
A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (NCT03542994)Evelo Biosciences, Inc.2019-04-24
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors (NCT03775850)Evelo Biosciences, Inc.2018-12-19
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (NCT03733353)Evelo Biosciences, Inc.2018-11-19

Track Evelo Biosciences, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.